Skip to main content

Advertisement

Table 1 Sample characterization of 736 intravitreal injections (IVIs)

From: Laser flare photometry: a cost-effective method for early detection of endophthalmitis after intravitreal injection of anti-VEGF agents

  N (%)
Drug injected
 Bevacizumab 113 (15.4%)
 Aflibercept 623 (84.6%)
Indications for IVI
 Age-related macular degeneration 469 (63.7%)
 Retinal venous occlusion 193 (26.2%)
 Diabetic macular edema 55 (7.5%)
 Telangiectasia 5 (0.7%)
 Myopic choroidal neovascular membrane 2 (0.3%)
 Proliferative retinopathy due to central arterial retinal occlusion 2 (0.3%)
 Other 10 (1.4%)